Vanda Pharmaceuticals IncNASDAQ:VNDA
- LAST PRICE6.2400
- TODAY'S CHANGE (%)-0.2600 (-4.0000%)
- Bid / Lots6.2700/ 1
- Ask / Lots6.4900/ 4
- Open / Previous Close6.4600 / 6.5000
- Day Range
- 52 Week Range
- Volume1,134,894
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | VNDA |
|---|---|---|
| 09:32 ET | 36085 | 6.53 |
| 09:34 ET | 6024 | 6.4523 |
| 09:36 ET | 3075 | 6.49 |
| 09:38 ET | 6483 | 6.45 |
| 09:39 ET | 4527 | 6.44 |
| 09:41 ET | 3904 | 6.45 |
| 09:43 ET | 6212 | 6.44 |
| 09:45 ET | 13619 | 6.465 |
| 09:48 ET | 525 | 6.48 |
| 09:50 ET | 6257 | 6.4707 |
| 09:52 ET | 725 | 6.47 |
| 09:54 ET | 3508 | 6.4772 |
| 09:56 ET | 1550 | 6.4781 |
| 09:57 ET | 4211 | 6.4897 |
| 09:59 ET | 445 | 6.47 |
| 10:01 ET | 1814 | 6.5 |
| 10:03 ET | 1225 | 6.485 |
| 10:06 ET | 2394 | 6.495 |
| 10:08 ET | 14550 | 6.4999 |
| 10:10 ET | 9052 | 6.43 |
| 10:12 ET | 1706 | 6.45 |
| 10:14 ET | 5033 | 6.45 |
| 10:17 ET | 1551 | 6.48 |
| 10:19 ET | 5380 | 6.48 |
| 10:21 ET | 8137 | 6.5088 |
| 10:24 ET | 15092 | 6.51 |
| 10:26 ET | 5693 | 6.505 |
| 10:28 ET | 5332 | 6.51 |
| 10:30 ET | 14178 | 6.53 |
| 10:32 ET | 16450 | 6.53 |
| 10:33 ET | 704 | 6.494 |
| 10:35 ET | 3146 | 6.4777 |
| 10:37 ET | 100 | 6.48 |
| 10:39 ET | 24171 | 6.49 |
| 10:42 ET | 100 | 6.5101 |
| 10:44 ET | 400 | 6.52 |
| 10:46 ET | 5387 | 6.555 |
| 10:50 ET | 7058 | 6.576 |
| 10:51 ET | 5812 | 6.6099 |
| 10:53 ET | 660 | 6.6005 |
| 10:55 ET | 3375 | 6.62 |
| 10:57 ET | 6063 | 6.65 |
| 11:00 ET | 16347 | 6.66 |
| 11:02 ET | 32860 | 6.6356 |
| 11:04 ET | 17353 | 6.635 |
| 11:06 ET | 500 | 6.5901 |
| 11:08 ET | 476 | 6.584 |
| 11:09 ET | 2160 | 6.58 |
| 11:11 ET | 4203 | 6.6 |
| 11:13 ET | 2600 | 6.6083 |
| 11:15 ET | 4131 | 6.6 |
| 11:18 ET | 200 | 6.565 |
| 11:20 ET | 900 | 6.5738 |
| 11:22 ET | 345 | 6.575 |
| 11:24 ET | 3125 | 6.5882 |
| 11:26 ET | 4645 | 6.5792 |
| 11:27 ET | 300 | 6.5701 |
| 11:29 ET | 8056 | 6.52 |
| 11:31 ET | 16169 | 6.49 |
| 11:33 ET | 11585 | 6.5 |
| 11:38 ET | 2095 | 6.505 |
| 11:40 ET | 500 | 6.505 |
| 11:42 ET | 1358 | 6.51 |
| 11:44 ET | 400 | 6.5 |
| 11:47 ET | 2800 | 6.525 |
| 11:49 ET | 100 | 6.511 |
| 11:51 ET | 100 | 6.515 |
| 11:54 ET | 500 | 6.525 |
| 11:56 ET | 9259 | 6.495 |
| 12:00 ET | 7781 | 6.46 |
| 12:02 ET | 1350 | 6.46 |
| 12:03 ET | 15208 | 6.445 |
| 12:05 ET | 2300 | 6.443 |
| 12:07 ET | 2600 | 6.44 |
| 12:12 ET | 11605 | 6.455 |
| 12:14 ET | 1930 | 6.46 |
| 12:16 ET | 706 | 6.455 |
| 12:18 ET | 1998 | 6.47 |
| 12:20 ET | 1000 | 6.45 |
| 12:21 ET | 100 | 6.445 |
| 12:23 ET | 1634 | 6.415 |
| 12:25 ET | 18589 | 6.4 |
| 12:27 ET | 2924 | 6.39 |
| 12:30 ET | 5558 | 6.375 |
| 12:32 ET | 1100 | 6.379 |
| 12:34 ET | 3513 | 6.36 |
| 12:36 ET | 3585 | 6.375 |
| 12:38 ET | 1475 | 6.375 |
| 12:39 ET | 1221 | 6.39 |
| 12:41 ET | 400 | 6.375 |
| 12:43 ET | 2500 | 6.3727 |
| 12:45 ET | 1500 | 6.35 |
| 12:48 ET | 601 | 6.36 |
| 12:50 ET | 350 | 6.3599 |
| 12:52 ET | 425 | 6.3599 |
| 12:54 ET | 21103 | 6.3587 |
| 12:56 ET | 7600 | 6.3599 |
| 12:57 ET | 6564 | 6.3501 |
| 12:59 ET | 1732 | 6.36 |
| 01:01 ET | 3138 | 6.3358 |
| 01:03 ET | 100 | 6.33 |
| 01:06 ET | 721 | 6.3361 |
| 01:08 ET | 3821 | 6.34 |
| 01:10 ET | 200 | 6.3399 |
| 01:12 ET | 100 | 6.335 |
| 01:14 ET | 1000 | 6.3312 |
| 01:15 ET | 1724 | 6.33 |
| 01:17 ET | 1400 | 6.325 |
| 01:19 ET | 3800 | 6.315 |
| 01:21 ET | 1436 | 6.315 |
| 01:24 ET | 2728 | 6.31 |
| 01:26 ET | 2946 | 6.3 |
| 01:28 ET | 2135 | 6.3 |
| 01:30 ET | 1300 | 6.31 |
| 01:32 ET | 1507 | 6.31 |
| 01:33 ET | 1100 | 6.305 |
| 01:35 ET | 6785 | 6.32 |
| 01:37 ET | 838 | 6.325 |
| 01:39 ET | 100 | 6.31 |
| 01:42 ET | 7155 | 6.31 |
| 01:44 ET | 1347 | 6.315 |
| 01:46 ET | 29244 | 6.29 |
| 01:48 ET | 684 | 6.29 |
| 01:50 ET | 38143 | 6.24 |
| 01:51 ET | 14506 | 6.26 |
| 01:53 ET | 3349 | 6.27 |
| 01:55 ET | 192 | 6.27 |
| 01:57 ET | 3312 | 6.25 |
| 02:02 ET | 1400 | 6.265 |
| 02:04 ET | 4000 | 6.2542 |
| 02:06 ET | 100 | 6.255 |
| 02:08 ET | 2121 | 6.27 |
| 02:09 ET | 12301 | 6.265 |
| 02:11 ET | 600 | 6.2613 |
| 02:13 ET | 1104 | 6.255 |
| 02:15 ET | 3387 | 6.245 |
| 02:18 ET | 606 | 6.24 |
| 02:20 ET | 4800 | 6.27 |
| 02:24 ET | 590 | 6.275 |
| 02:26 ET | 3516 | 6.29 |
| 02:29 ET | 1100 | 6.28 |
| 02:31 ET | 302 | 6.27 |
| 02:33 ET | 1703 | 6.274 |
| 02:36 ET | 1156 | 6.275 |
| 02:38 ET | 1625 | 6.2799 |
| 02:40 ET | 2895 | 6.255 |
| 02:42 ET | 2606 | 6.26 |
| 02:44 ET | 6441 | 6.275 |
| 02:45 ET | 2061 | 6.275 |
| 02:47 ET | 3784 | 6.29 |
| 02:49 ET | 1000 | 6.294 |
| 02:51 ET | 2669 | 6.295 |
| 02:54 ET | 22082 | 6.2999 |
| 02:56 ET | 323 | 6.305 |
| 02:58 ET | 9570 | 6.335 |
| 03:00 ET | 7606 | 6.335 |
| 03:03 ET | 300 | 6.33 |
| 03:05 ET | 750 | 6.3336 |
| 03:07 ET | 700 | 6.345 |
| 03:12 ET | 1000 | 6.3402 |
| 03:14 ET | 1200 | 6.34 |
| 03:16 ET | 1997 | 6.34 |
| 03:18 ET | 1200 | 6.305 |
| 03:20 ET | 3148 | 6.305 |
| 03:21 ET | 4255 | 6.29 |
| 03:23 ET | 1801 | 6.29 |
| 03:25 ET | 2785 | 6.2901 |
| 03:27 ET | 2189 | 6.3 |
| 03:30 ET | 100 | 6.295 |
| 03:32 ET | 7424 | 6.28 |
| 03:34 ET | 100 | 6.2847 |
| 03:36 ET | 210 | 6.28 |
| 03:38 ET | 9901 | 6.275 |
| 03:39 ET | 546 | 6.275 |
| 03:41 ET | 7702 | 6.305 |
| 03:43 ET | 2300 | 6.31 |
| 03:45 ET | 570 | 6.315 |
| 03:48 ET | 1590 | 6.315 |
| 03:50 ET | 300 | 6.315 |
| 03:52 ET | 1621 | 6.31 |
| 03:54 ET | 2278 | 6.305 |
| 03:56 ET | 15684 | 6.25 |
| 03:57 ET | 16112 | 6.24 |
| 03:59 ET | 122999 | 6.24 |
Jun 13, 2024
DJ Vanda Pharmaceuticals Shares Rise 11% After New Buyout Offer From Future Pak, from 10:25AM ET on Thursday Jun 13, 2024 by Dow Jones
10:25AM ET on Thursday Jun 13, 2024 by Dow JonesVanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak, from 10:03AM ET on Thursday Jun 13, 2024 by Dow Jones
10:03AM ET on Thursday Jun 13, 2024 by Dow JonesPress Release: Vanda Pharmaceuticals Confirms Receipt of Revised Unsolicited Takeover Proposal from Future Pak, from 10:03AM ET on Thursday Jun 13, 2024 by Dow Jones
10:03AM ET on Thursday Jun 13, 2024 by Dow Jones
Jun 10, 2024
Glancy Prongay & Murray LLP Announces Investigation of Vanda Pharmaceuticals Inc., from 8:14AM ET on Monday Jun 10, 2024 by Dow Jones
8:14AM ET on Monday Jun 10, 2024 by Dow Jones
Jun 6, 2024
Vanda Pharmaceuticals Confirms Receipt of Unsolicited, Non-Binding Indication of Interest from Cycle Group Holdings Ltd., from 9:24AM ET on Thursday Jun 06, 2024 by Dow Jones
9:24AM ET on Thursday Jun 06, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Vanda Pharmaceuticals Inc | 378.3M | -73.8x | -37.98% |
Akebia Therapeutics Inc | 234.7M | -4.8x | --- |
Anika Therapeutics Inc | 385.1M | -5.0x | --- |
Adaptive Biotechnologies Corp | 486.3M | -2.1x | --- |
Agenus Inc | 336.0M | -1.2x | --- |
Sutro Biopharma Inc | 314.9M | -1.8x | --- |
Company Information
Vanda Pharmaceuticals Inc. is a biopharmaceutical company, which is focused on the development and commercialization of therapies to address high unmet medical needs and improve the lives of patients. The Company’s commercial portfolio is comprised of three products: HETLIOZ for the treatment of non-24-hour sleep-wake disorder (Non-24) and for the treatment of nighttime sleep disturbances in smith-magenis syndrome (SMS), Fanapt (iloperidone) for the treatment of bipolar I disorder and a long acting injectable (LAI) formulation for the treatment of schizophrenia, and PONVORY (ponesimod) for the treatment of inflammatory/autoimmune disorders, including ulcerative colitis, psoriasis, Crohn's disease, atopic dermatitis, eosinophilic esophagitis and alopecia areata. The Company also has a range of drugs in development, including Tradipitant (VLY-686), VHX-896, VSJ-110, VPO-227, VTR-297, VQW-765, VCA-894A and Type 2S (CMT2S).
Contact Information
- Headquarters
- SUITE 300E, 2200 PENNSYLVANIA AVE NWWASHINGTON, DC, United States 20037
- Phone
- 202-734-3400
- Fax
- 202-296-1450
Executives
- Chairman of the Board, President, Chief Executive Officer
- Mihael Polymeropoulos
- Chief Financial Officer, Senior Vice President, Treasurer
- Kevin Moran
- Senior Vice President, Chief Marketing Officer
- Joakim Wijkstrom
- Senior Vice President, General Counsel, Secretary
- Timothy Williams
- Senior Vice President - Business Development
- Gunther Birznieks
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $378.3M |
|---|---|
Revenue (TTM) | $177.6M |
Shares Outstanding | 58.2M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.77 |
EPS | $-0.08 |
Book Value | $9.47 |
P/E Ratio | -73.8x |
Price/Sales (TTM) | 2.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.18% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
